CancerIQ Raises $14M Series B Funding to Improve Access to Innovations in Cancer Early Detection and Prevention
CancerIQ, a platform powering early cancer detection and prevention across broad patient populations, has closed a $14 million Series B financing round co-led by Merck Global Health Innovation Fund (Merck GHI) and Amgen Ventures. Other investors participating in the round were McKesson Ventures; OSF HealthCare; a current health system customer; and CancerIQ’s Series A lead investor, HealthX Ventures. This funding round comes one month after a report from the President’s Cancer Panel calling for “urgent and immediate action” to close gaps in cancer screening, risk assessment,...